AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nextech3D.AI Corporation

CAD 0.1 -$0.05 (-35.48%)
CNQ · 15 Sep 2026 19:57 UTC
Previous Close
CAD 0.1
Day Range
CAD 0.1CAD 0.1
Year Range
CAD 0.1CAD 0.25
Market Cap
23.34M
AVG Volume
124.19K
Trailing/Forward PE
-5.71/-
PEG ratio
-0.08
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
Canadian Securities ExchangeCA
Revenue (CAD)
-10M010M20M30M20182019202020212022202320242025
NTAR.CN Revenue (CAD) by year
PeriodRevenue (CAD)
20251.88M
20243.18M
20235.03M
2022-3.56M
202126.39M
202017.69M
20196.31M
201890.62K
Net Income (CAD)
-40M-30M-20M-10M020182019202020212022202320242025
NTAR.CN Net Income (CAD) by year
PeriodNet Income (CAD)
2025-4.76M
2024-6M
2023-27.14M
2022-27.42M
2021-32.62M
2020-15.59M
2019-9.76M
2018-2.14M
Operating Income (CAD)
-40M-30M-20M-10M010M20182019202020212022202320242025
NTAR.CN Operating Income (CAD) by year
PeriodOperating Income (CAD)
2025-5.24M
2024-6.54M
2023-19.71M
2022-23.2M
2021-35.27M
2020-15.6M
2019608K
2018-2.16M
EBITDA (CAD)
-40M-30M-20M-10M020182019202020212022202320242025
NTAR.CN EBITDA (CAD) by year
PeriodEBITDA (CAD)
2025-5.08M
2024-6.82M
2023-24.85M
2022-19.98M
2021-32.87M
2020-15.01M
2019-5.53M
2018-1.65M
Cash Flows (CAD)
-30M-20M-10M020182019202020212022202320242025
NTAR.CN Cash Flows (CAD) by year
PeriodCash Flows (CAD)
2025-2.42M
2024-4.71M
2023-8.84M
2022-15.44M
2021-22.29M
2020-14.06M
2019-3.85M
2018-1.41M
EPS (CAD)
-0.4-0.3-0.2-0.1-020182019202020212022202320242025
NTAR.CN EPS (CAD) by year
PeriodEPS (CAD)
2025-0.02
2024-0.04
2023-0.23
2022-0.26
2021-0.38
2020-0.22
2019-0.16
2018-0.05
Expenses (CAD)
020M40M60MR&DSG&ACapex20182019202020212022202320242025
NTAR.CN Expenses (CAD) by year
PeriodExpenses (CAD)
20256.57M
20247.96M
202318.43M
202219.69M
202142.15M
202028.03M
20198.9M
20182.47M
Cash & Debt (CAD)
05M10M15MCashLong Term DebtShort Term Debt20182019202020212022202320242025
NTAR.CN Cash & Debt (CAD) by year
PeriodCash & Debt (CAD)
2025414.64K
202475.62K
2023907.85K
20223.78M
20217.24M
202010.68M
20192.85M
20181.46M
Debt ratios
-0.0500.050.10.1520212022202320242025
NTAR.CN Debt ratios by year
PeriodDebt ratios
20250
2024-0.01
20230
20220.04
20210.11
Margins
-25%0%25%50%75%100%20182019202020212022202320242025
NTAR.CN Margins by year
PeriodMargins
202577.08%
202462.21%
202328.57%
2022-13.25%
202138.46%
202055.7%
201955.4%
201858.29%
Return on Capital
-1000%0%1000%2000%20182019202020212022202320242025
NTAR.CN Return on Capital by year
PeriodReturn on Capital
2025318%
2024130.88%
20231808.32%
2022-208.86%
2021-134.44%
2020-69.55%
2019-138.07%
2018-52.82%
Shares Outstanding
0100M200M300M20182019202020212022202320242025
NTAR.CN Shares Outstanding by year
PeriodShares Outstanding
2025223.2M
2024160.85M
2023127.5M
2022100.2M
202197.55M
202076.29M
201973.2M
201839.14M
Book Value Per Share (CAD)
-0.100.10.20.320182019202020212022202320242025
NTAR.CN Book Value Per Share (CAD) by year
PeriodBook Value Per Share (CAD)
2025-0.01
2024-0.03
2023-0.01
20220.13
20210.25
20200.29
20190.1
20180.1
Total Assets (CAD)
010M20M30M20182019202020212022202320242025
NTAR.CN Total Assets (CAD) by year
PeriodTotal Assets (CAD)
20252.19M
20241.27M
20232.99M
202217.14M
202129.51M
202029.08M
20198.64M
20184.27M
Free Cash Flow Yield
-150%-100%-50%0%50%100%med -10.27%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NTAR.CN Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-12.38%
Sep 26-11.79%
Sep 26-11.79%
Aug 26-10.32%
Aug 26-10.32%
Aug 26-10.77%
Aug 26-11.79%
Jul 26-11.26%
Jul 26-10.32%
Jul 26-9.91%
Jul 26-8.84%
Jul 26-8.84%
Jun 26-8.04%
Jun 26-7.75%
Jun 26-7.75%
Jun 26-7.48%
May 26-7.23%
May 26-7.23%
May 26-7.23%
May 26-6.38%
May 26-6.38%
Apr 26-7%
Apr 26-8.35%
Apr 26-9.04%
Apr 26-8.35%
Mar 26-11.69%
Mar 26-10.02%
Mar 26-11.22%
Mar 26-10.39%
Feb 26-9.68%
Feb 26-9.05%
Feb 26-10.39%
Feb 26-10.02%
Jan 26-8.5%
Jan 26-8.25%
Jan 26-8.5%
Jan 26-9.68%
Jan 26-9.05%
Dec 25-8.12%
Dec 25-8.63%
Dec 25-8.63%
Dec 25-9.86%
Nov 25-7.89%
Nov 25-10.23%
Nov 25-8.91%
Nov 25-9.86%
Oct 25-7.67%
Oct 25-7.08%
Oct 25-7.67%
Oct 25-7.27%
Oct 25-6.42%
Sep 25-9.15%
Sep 25-7.93%
Sep 25-11.16%
Sep 25-16.23%
Aug 25-17%
Aug 25-18.79%
Aug 25-17%
Aug 25-17%
Aug 25-21%
Jul 25-21%
Jul 25-25.5%
Jul 25-29.75%
Jul 25-32.45%
Jun 25-53.29%
Jun 25-83.74%
Jun 25-97.7%
Jun 25-83.74%
May 25-83.74%
May 25-97.7%
May 25-83.74%
May 25-97.7%
May 25-97.7%
Apr 25-97.7%
Apr 25-97.7%
Apr 25-65.13%
Apr 25-73.27%
Mar 25-118.54%
Mar 25-118.54%
Mar 25-118.54%
Mar 25-105.37%
Feb 25-94.83%
Feb 25-86.21%
Feb 25-86.21%
Feb 25-86.21%
Jan 25-94.83%
Jan 25-67.74%
Jan 25-63.22%
Jan 25-72.95%
Jan 25-59.27%
Dec 2465.15%
Dec 2473.29%
Dec 2473.29%
Dec 2473.29%
Nov 2465.15%
Nov 2458.63%
Nov 2448.86%
Nov 2458.63%
Nov 2453.3%
Oct 2448.86%
Price to Sales
0510152025med 11.33Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
NTAR.CN Price to Sales by year
PeriodPrice to Sales
Sep 2610.79
Sep 2611.33
Sep 2611.33
Aug 2612.94
Aug 2612.94
Aug 2612.4
Aug 2611.33
Jul 2611.86
Jul 2612.94
Jul 2613.48
Jul 2615.1
Jul 2615.1
Jun 2615.99
Jun 2616.58
Jun 2616.58
Jun 2617.17
May 2617.77
May 2617.77
May 2617.77
May 2620.13
May 2620.13
Apr 2618.36
Apr 2615.4
Apr 2614.21
Apr 2615.4
Mar 2614.98
Mar 2617.48
Mar 2615.61
Mar 2616.85
Feb 2618.1
Feb 2619.35
Feb 2616.85
Feb 2617.48
Jan 2620.6
Jan 2621.22
Jan 2620.6
Jan 2618.1
Jan 2619.35
Dec 2516.34
Dec 2515.38
Dec 2515.38
Dec 2513.45
Nov 2516.82
Nov 2512.97
Nov 2514.9
Nov 2513.45
Oct 2517.3
Oct 2518.74
Oct 2517.3
Oct 2518.26
Oct 2520.66
Sep 2513.09
Sep 2515.11
Sep 2510.74
Sep 257.39
Aug 257.05
Aug 256.38
Aug 257.05
Aug 257.05
Aug 255.71
Jul 255.71
Jul 254.7
Jul 254.03
Jul 253.69
Jun 252.78
Jun 251.77
Jun 251.52
Jun 251.77
May 251.77
May 251.52
May 251.77
May 251.52
May 251.52
Apr 251.52
Apr 251.52
Apr 252.27
Apr 252.02
Mar 251.35
Mar 251.35
Mar 251.35
Mar 251.52
Feb 251.68
Feb 251.85
Feb 251.85
Feb 251.85
Jan 251.68
Jan 252.36
Jan 252.53
Jan 252.19
Jan 252.69
Dec 241.41
Dec 241.25
Dec 241.25
Dec 241.25
Nov 241.41
Nov 241.57
Nov 241.88
Nov 241.57
Nov 241.73
Oct 241.88
Price/Operating Cashflow
11.522.53med 1.6Oct 24Oct 24Nov 24Nov 24Nov 24Dec 24Dec 24
NTAR.CN Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Dec 241.44
Dec 241.28
Dec 241.28
Dec 241.28
Nov 241.44
Nov 241.6
Nov 241.92
Nov 241.6
Nov 241.76
Oct 241.92
Oct 242.24
Oct 242.08
Oct 242.56
Price to Book
02468med 3.3Jul 22Oct 22Feb 23May 23Sep 23Dec 23Mar 24
NTAR.CN Price to Book by year
PeriodPrice to Book
Mar 242.38
Mar 242.38
Mar 242.73
Mar 242.73
Mar 243.22
Feb 242.38
Feb 242.38
Feb 242.45
Feb 242.87
Jan 242.52
Jan 242.94
Jan 243.01
Jan 243.15
Dec 232.31
Dec 231.62
Dec 232.54
Dec 232.59
Dec 231.24
Nov 231.3
Nov 231.35
Nov 231.46
Nov 231.41
Oct 232.16
Oct 231.62
Oct 232.59
Oct 232.7
Sep 232.81
Sep 232.49
Sep 232.85
Sep 233.2
Sep 233.29
Aug 232.89
Aug 233.34
Aug 233.38
Aug 233.47
Jul 233.65
Jul 233.74
Jul 235.07
Jul 234.63
Jun 235.07
Jun 234.43
Jun 235.88
Jun 235.95
Jun 235.72
May 235.27
May 235.27
May 234.96
May 234.66
Apr 234.43
Apr 234.66
Apr 234.81
Apr 234.35
Mar 235.27
Mar 234.49
Mar 234.62
Mar 234.37
Mar 234.31
Feb 234.49
Feb 234.74
Feb 235.17
Feb 234.74
Jan 234.92
Jan 236.4
Jan 235.48
Jan 234.62
Dec 224.8
Dec 224.29
Dec 224.82
Dec 224.93
Dec 225.09
Nov 225.14
Nov 225.67
Nov 224.72
Nov 225.04
Oct 226.84
Oct 224.98
Oct 224.08
Oct 224.03
Sep 224.19
Sep 222.77
Sep 222.95
Sep 222.92
Sep 222.84
Aug 222.99
Aug 223.21
Aug 223.43
Aug 223.32
Jul 222.77
Jul 223.06
Jul 224.12
Jul 223.06
Jun 222.48
Jun 222.65
Jun 222.21
Jun 221.71
Jun 222.57
May 222.25
May 221.79
May 222.29
May 222.89
Nextech3D.AI Corporation
NTAR.CN
Stockpicker

Video analysis: NTAR.CN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NTAR.CN

Traders shorten odds on October debut for Anthropic

proactiveinvestors.com · 12 Aug 2026

Traders shorten odds on October debut for Anthropic

Betting markets now put a 62% probability on Anthropic listing its shares by the end of October, up 19 percentage points, as the artificial intelligence...

Citi upgrades Flutter after 13% share price slide

proactiveinvestors.com · 7 Aug 2026

Citi upgrades Flutter after 13% share price slide

Citi has upgraded Flutter Entertainment PLC (LSE:FLTR, NYSE:FLUT) to 'neutral' following the gambling group's second-quarter results, arguing that a 13%...

JD Sports appoints former IKEA boss Peter Agnefjäll as chair

proactiveinvestors.com · 7 Aug 2026

JD Sports appoints former IKEA boss Peter Agnefjäll as chair

JD Sports Fashion PLC (LSE:JD., OTC:JDSPY) has appointed Peter Agnefjäll as chair of the board with effect from 1 September 2026. Agnefjäll succeeds Darren...

Nextech3D.ai reports increase in new customer contracts through first seven months of 2026

proactiveinvestors.com · 6 Aug 2026

Nextech3D.ai reports increase in new customer contracts through first seven months of 2026

Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS) reported growth in new customer contracts and contracted value across its Eventdex, Map D and KraftyLab...

Nextech3D.ai advances ARway acquisition as valuations confirmed

proactiveinvestors.com · 4 Aug 2026

Nextech3D.ai advances ARway acquisition as valuations confirmed

Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF, FRA:1SS), an AI-first event technology and 3D modeling company, has received final fairness opinions supporting its...

GSK hits three-month high as vaccines help earnings top forecasts

proactiveinvestors.com · 28 Jul 2026

GSK hits three-month high as vaccines help earnings top forecasts

GSK PLC (LSE:GSK, NYSE:GSK) shares jumped to a three-month high after the drugmaker beat second-quarter expectations across its main measures and...

Nasdaq 100 enters correction as sell-off deepens, while Coke and Sherwin-Williams lead Dow

proactiveinvestors.com · 28 Jul 2026

Nasdaq 100 enters correction as sell-off deepens, while Coke and Sherwin-Williams lead Dow

1:00pm: Chip selloff continues Chris Beauchamp, chief market analyst at IG, said another round of selling in tech stocks is keeping pressure on global...

Replimune shares fall after FDA reviewers raise doubts over RP1 melanoma drug efficacy

proactiveinvestors.com · 28 Jul 2026

Replimune shares fall after FDA reviewers raise doubts over RP1 melanoma drug efficacy

Replimune (NASDAQ: REPL) shares fell nearly 31% on Tuesday after US Food and Drug Administration (FDA) staff reviewers raised concerns over the...

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.